

We describe here the paradoxical development of spontaneous experimental autoimmune encephalomyelitis (EAE) in transgenic mice expressing a myelin oligodendrocyte glycoprotein (MOG)-specific T cell antigen receptor (TCR) in the absence of MOG. We report that in Mog-deficient mice (Mog /), the autoimmune response by transgenic T cells is redirected to a neuronal cytoskeletal self antigen, neurofilament-M (NF-M). Although components of radically different protein classes, the cross-reacting major histocompatibility complex I-A b -restricted epitope sequences of MOG 35-55 and NF-M 18-30 share essential TCR contact positions. This pattern of cross-reaction is not specific to the transgenic TCR but is also commonly seen in MOG 35-55 -I-A b -reactive T cells. We propose that in the C57BL/6 mouse, MOG and NF-M response components add up to overcome the general resistance of this strain to experimental induction of autoimmunity. Similar cumulative responses against more than one autoantigen may have a role in spontaneously developing human autoimmune diseases. © 2009 Nature America, Inc. All rights reserved.
| EMTREE drug terms: | myelin oligodendrocyte glycoproteinneurofilament M proteinT lymphocyte receptor |
|---|---|
| EMTREE medical terms: | allergic encephalomyelitisanimal cellanimal experimentanimal modelarticleautoimmunitycontrolled studycross reactionin vivo studymajor histocompatibility complexmousemultiple sclerosisnonhumanpriority journalprotein deficiencyprotein expressionT lymphocytewild type |
| MeSH: | Amino Acid SequenceAnimalsAutoantigensCross ReactionsDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalMiceMice, Inbred C57BLMice, TransgenicMolecular Sequence DataMultiple SclerosisMyelin SheathMyelin-Associated GlycoproteinNeurofilament ProteinsReceptors, Antigen, T-CellT-Lymphocytes |
| Species Index: | MusMus musculus |
Autoantigens; Myelin-Associated Glycoprotein; Neurofilament Proteins; Receptors, Antigen, T-Cell; neurofilament protein M, 111365-29-8; oligodendrocyte-myelin glycoprotein
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| Fundação para a Ciência e a Tecnologia See opportunities | ||
| National Multiple Sclerosis Society See opportunities | RG3195B8/2 | |
| Fuel Cell Technologies Program | SFRH/BD/15885/2005 | FCT |
| Israel Science Foundation | ISF | |
| Deutsche Forschungsgemeinschaft See opportunities | SFB,A1,B6 | |
| PL 018637 |
MogCre/Cre, Nefm–/–, 2D2 and Mog–/– mice were generously provided by A. Waisman (Johannes Gutenberg University of Mainz), J.-P. Julien (Laval University), V.K. Kuchroo (Harvard Medical School) and D. Pham-Dinh (INSERM UMR 546). We thank F. Lottspeich for granting us permission to use his mass spectrometer. We thank L. Penner and I. Arnold-Ammer for technical support. This project was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereiche (SFB) 571, Projects A1 and B6) and the Max Planck Society. H.S.D. is supported by a PhD fellowship (Portuguese Fundac¸ão para a Ciência ea Tecnologia (FCT) program SFRH/BD/15885/2005). Part of the study (conducted by H.W., R.L. and H.L.) was funded by the EU Project Neuropromise (PL 018637), and A.B.-N. was supported by the Israel Science Foundation and the National Multiple Sclerosis Society of New York (RG3195B8/2). A.B.-N. is an Alexander von Humboldt Prize Awardee.
Wekerle, H.; Department of Neuroimmunology, Max Planck Institute of Neurobiology, Germany;
© Copyright 2009 Elsevier B.V., All rights reserved.
© MEDLINE® is the source for the MeSH terms of this document.